Use of external data to inform overall survival extrapolation in NICE technology appraisals for oncology drugs.
Aim: To assess use of external evidence for overall survival (OS) estimation in oncology single-technology appraisals (STAs) by the National Institute for Health and Care Excellence (NICE). Methods: STAs for oncology drugs appraised by NICE between January 2021 and March 2023 were identified. For ea...
| Published in: | Journal of Medical Economics Vol. 28; no. 1; pp. 803 - 814 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Published: |
Taylor & Francis Ltd
Dec2025
|
| Online Access: | View this record in EBSCOhost |